GlycoNet researchers found more efficient ways to produce montbretin A, a potential anti-diabetes compound.
Category: Research Highlight
Sugars could be the key to an earlier test for breast cancer
GlycoNet scientists are looking for clues in sugars to develop early diagnostics for breast cancer.
GlycoNet scientists develop new tools to study the immune system
New research lays foundation for future breakthroughs in fighting neurodegenerative diseases and cancer.
The light at the end of the tunnel for heart failure
GlycoNet Investigators identified carbohydrate-derived molecules that may hold the key to preventing and treating the disease for which there is currently no cure.
Using health economics to find a better way to screen for prostate cancer
GlycoNet scientists aim to change the way we diagnose the disease with a new blood test.
Helping our immune system bypass antibiotic resistance
GlycoNet scientists are searching for ways to weaken bacteria’s ability to develop resistance.
New family of enzymes reveals the Achilles’ heel of fungal pathogens
GlycoNet scientists share findings that could lead to therapeutics to treat fungal infections.
Preventing hospital-acquired pneumonia
GlycoNet researchers identified a previously unrecognized family of enzymes that put us at risk for deadly diseases.
Preventing a comeback
GlycoNet researchers work to limit the spreads of tuberculosis
How a carbohydrate-derived dietary supplement could treat muscular dystrophy
GlycoNet researchers identified a natural supplement that could boost muscle fiber formation.
English 
French